Unilateral cerebral cortical encephalitis (CCE) with positive anti-MOG antibodies : A case report

Copyright © 2021 the Author(s). Published by Wolters Kluwer Health, Inc..

RATIONALE: Nowadays, myelin oligodendrocyte glycoprotein (MOG)-antibody-associated disease (MOGAD) is regarded as an independent inflammatory demyelinating disease. Here, we report a rare case of unilateral cerebral cortical encephalitis (CCE) with positive anti-MOG antibodies.

PATIENT CONCERNS: A 19-year-old woman was admitted to our hospital owing to acute onset fever and headache. Four days later, she experienced a focal seizure that progressed to generalized tonic-clonic seizures.

DIAGNOSIS: Brain magnetic resonance imaging (MRI) demonstrated cortical lesions in the left cerebral hemisphere on T2-weighted fluid-attenuated inversion recovery imaging. The patient was positive for anti-MOG antibodies in serum and diagnosed with anti-MOG antibody-associated unilateral CCE.

INTERVENTIONS: She was administrated with intravenous methylprednisolone followed by oral corticosteroids.

OUTCOMES: On day 14 after admission, a repeat MRI revealed partial resolution of the initial abnormalities. The patient received a quick recovery without residual symptoms.

CONCLUSIONS: Unilateral CCE with positive anti-MOG antibodies has emerged as a special clinical phenotype of MOGAD. It should be emphasized that the characteristic neuroradiological features of CCE would be an important clue to the correct diagnosis of MOGAD.

Medienart:

E-Artikel

Erscheinungsjahr:

2021

Erschienen:

2021

Enthalten in:

Zur Gesamtaufnahme - volume:100

Enthalten in:

Medicine - 100(2021), 20 vom: 21. Mai, Seite e26087

Sprache:

Englisch

Beteiligte Personen:

Nie, Hongbing [VerfasserIn]
Gao, Haifeng [VerfasserIn]
Li, Yongqiu [VerfasserIn]
Shen, Yaoyao [VerfasserIn]

Links:

Volltext

Themen:

Antibodies
Case Reports
Journal Article
Myelin-Oligodendrocyte Glycoprotein

Anmerkungen:

Date Completed 01.06.2021

Date Revised 23.04.2022

published: Print

Citation Status MEDLINE

doi:

10.1097/MD.0000000000026087

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM32560746X